Emerald Health Therapeutics (CVE:EMH) Trading Down 3.8% – Should You Sell?
by Doug Wharley · The Cerbat GemShares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) fell 3.8% during trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The company has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The company has a fifty day moving average price of C$0.26 and a two-hundred day moving average price of C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.